Stay updated with breaking news from Relevant State. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PARIS, FRANCE / ACCESSWIRE / October 24, 2023 / Abivax SA (PARIS:FR) (" Abivax " or the " Company "), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's
EQS-News: ABIVAX / Key word: Miscellaneous Abivax announces trading resumption of its ordinary shares on Euronext Paris 20.10.2023 / 15:45 CET/CEST The issuer is...
Abivax Announces Temporary Trading Halt of its Ordinary Shares on Euronext ...
EQS-News: ABIVAX / Key word: Temporary Suspension Abivax announces temporary trading halt of its ordinary shares on Euronext Paris 20.10.2023 / 08:45 CET/CEST The...
EQS-News: ABIVAX / Key word(s): IPO Abivax announces the pricing of its Initial Public Offering on the Nasdaq Global Market&...